Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Genesys (CEGE) -- Ignore unavailable to you. Want to Upgrade?

To: david james who wrote (841)	4/1/2000 10:10:00 AM
From: John Madarasz	Respond to of 1298

bio's are a buy... securitytrader.com

To: david james who wrote (841)	4/2/2000 10:19:00 PM
From: rupers	Respond to of 1298

David I looked through the "Late Breaking Research Session" abstracts and didn't see Cell Genesys mentioned in any ... were any of the CEGE-researchers listed by name in any of these (I saw EntreMed & Chromavision Med mentioned)? The abstracts for the Late Breakers are supposed to be the most significant, and they have a separate break-out session on Tuesday, April 4th. Regardless, shorters would be wary of shorting biotechs this week ... I would expect more than normal press releases on biotech/cancer research, which hopefully gives a little bull run for biotechs. I noticed that the Biotech composite started its big run last mid-November, just after the International Conference (AACR-NCI-EDRTC) on Molecular Targets and Cancer Theraputics in Washington, DC from Nov 16-19, 1999. Hoping CEGE and AVAN start a big run!